Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Other financing activities: 2020-2025

Historic Other financing activities for Sotera Health (SHC) over the last 6 years, with Sep 2025 value amounting to -$539,000.

  • Sotera Health's Other financing activities rose 15.52% to -$539,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year decrease of 2972.73%. This contributed to the annual value of -$2.3 million for FY2024, which is 27.61% down from last year.
  • Per Sotera Health's latest filing, its Other financing activities stood at -$539,000 for Q3 2025, which was up 31.69% from -$789,000 recorded in Q2 2025.
  • In the past 5 years, Sotera Health's Other financing activities registered a high of $24.5 million during Q1 2023, and its lowest value of -$26.6 million during Q2 2023.
  • For the 3-year period, Sotera Health's Other financing activities averaged around -$558,636, with its median value being -$672,000 (2024).
  • Over the last 5 years, Sotera Health's Other financing activities had its largest YoY gain of 5,950.96% in 2023, and its largest YoY loss of 4,065.99% in 2023.
  • Quarterly analysis of 5 years shows Sotera Health's Other financing activities stood at $74,000 in 2021, then slumped by 590.54% to -$363,000 in 2022, then soared by 525.90% to $1.5 million in 2023, then slumped by 143.47% to -$672,000 in 2024, then grew by 15.52% to -$539,000 in 2025.
  • Its Other financing activities was -$539,000 in Q3 2025, compared to -$789,000 in Q2 2025 and -$704,000 in Q1 2025.